Androgen deprivation therapy did not appear to increase risk for dementia, vascular dementia or Alzheimer disease among veterans with nonmetastatic prostate cancer, according to an observational cohort study published in JAMA Oncology.
“There is conflicting evidence on the association of ADT and dementia. [However,] these results may mitigate concerns regarding the long-term risks of ADT on cognitive health in the treatment of prostate cancer,” Rishi Deka, PhD, researcher in the department of radiation medicine and applied sciences at University of California San Diego School of Medicine, and colleagues wrote.
AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals
View past polls »
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.